🇺🇸 FDA
Pipeline program

new extensively hydrolysed formula

UP08-ALLAR

Unknown other completed

Quick answer

new extensively hydrolysed formula for Protein Allergy is a Unknown program (other) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Protein Allergy
Phase
Unknown
Modality
other
Status
completed

Clinical trials